Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update
Go back to Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update| Starpharma Holdings Ltd Sponsored ADR (AMEX: SPHRY) | Delayed: 5.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.40 | 52 Week High | $6.47 | |||
| Open | $5.40 | 52 Week Low | $3.98 | |||
| Day High | $5.40 | P/E | N/A | |||
| Day Low | $5.40 | EPS | $0.00 | |||
| Volume | 6,941,864 | |||||
| CRESSET PREC METALS (AMEX: SPL) | Delayed: 2.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $2.00 | |||
| Open | $2.00 | 52 Week Low | $2.00 | |||
| Day High | $2.00 | P/E | N/A | |||
| Day Low | $2.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
